Adage Capital Partners Gp, L.L.C. Edgewise Therapeutics, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 21,509 shares of EWTX stock, worth $637,096. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,509
Previous 49,597
56.63%
Holding current value
$637,096
Previous $893,000
35.72%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$445 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$264 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$178 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$173 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$164 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.87B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...